Search Results 851-860 of 16090 for anti-TNF drugs

  1. Bacitracin and polymyxin b (topical application route) - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Neomycin, polymyxin b, and bacitracin (ophthalmic route) - Side effects & dosage - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  3. Telomerase targeting drug demonstrates benefit in myelofibrosis treatment - Mayo Clinic News Network

    "We also observed that Imtelstat demonstrated selective anti-clonal activity, inhibiting the growth of cancer cells, which we had not previously documented with ...

  4. Sulfamethoxazole/trimethoprim (intravenous route) - Mayo Clinic

    Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

  5. Breast Cancer Clinical Trials

    Drugs used in chemotherapy, such as carboplatin ... therapy medication as prescribed (medication adherence). ... anti-HER2 therapies, such as trastuzumab ...

  6. Enfortumab vedotin-ejfv (intravenous route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  7. Bone-building medicines include: Teriparatide (Forteo). Abaloparatide (Tymlos). Romosozumab (Evenity). These types of medicine are typically reserved for ...

  8. Oxycodone and naloxone (oral route) - Side effects & dosage - Mayo Clinic

    Oxycodone belongs to the group of medicines called opioid analgesics (pain medicines). It acts on the central nervous system (CNS) to relieve pain. Naloxone is ...

  9. Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma - Mayo Clinic

    - History of acute or chronic active hepatitis B or C infection. - Positive for human immunodeficiency virus (HIV) unless taking appropriate anti-HIV

  10. Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (HIMALAYA) - Mayo Clinic

    The purpose of this study is to assess the effectiveness and safety of durvalumab plus tremelimumab combination therapy and durvalumab monotherapy versus ...